MEP1A contributes to tumor progression and predicts poor clinical outcome in human hepatocellular carcinoma
Hepatology2015Vol. 63(4), pp. 1227–1239
Citations Over TimeTop 19% of 2015 papers
Hanyue Ouyang, Jing Xu, Jun Luo, Ruhai Zou, Keng Chen, Yong Le, Yong‐Fa Zhang, Wei Wei, Rong Guo, Ming Shi
Abstract
MEP1A is a novel prognostic predictor in HCC and plays an important role in the development and progression of HCC.
Related Papers
- → The Prognostic Value of Circulating Tumor Cells in Patients with Melanoma: A Systematic Review and Meta-analysis(2006)214 cited
- → Epigenetic Silencing of miR-338-3p Contributes to Tumorigenicity in Gastric Cancer by Targeting SSX2IP(2013)76 cited
- → Microrna-136 promotes proliferation and invasion ingastric cancer cells through Pten/Akt/P-Akt signaling pathway(2018)21 cited
- Prognostic significance of osteopontin in patients with non-small cell lung cancer: results from a meta-analysis.(2015)
- → Artificial Neural Network Model to Predict Post-Hepatectomy Early Recurrence of Hepatocellular Carcinoma without Macroscopic Vascular Invasion(2020)2 cited